Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. M. Short, P. A. Williamson, L. McKinlay, D. Menzies, B. J. Lipworth (Dundee, United Kingdom). Relative sensitivity of markers of activated eosinophils in clinical trials for asthma. Eur Respir J 2010; 36: Suppl. 54, 5491

Member's Comments

No comment yet.

Related content which might interest you: The effect of statin usage on airway inflammatiory cells and markers, and clinical indices in asthmatic patients Source: Annual Congress 2011 - Asthma management and response Year: 2011 Variability and lack of predictive ability of asthma end-points in clinical trials Source: Eur Respir J 2002; 20: 1102-1109 Year: 2002 Comparison of Nε-(carboxymethyl)lysine levels and percentage of eosinophils in induced sputum for assessment of small airway involvements in asthma Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009 Sputum mast cells associate with clinical and inflammatory features of asthma Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 The use of sputum differential cell counts and soluble phase measurements to assess airway inflammation in children with asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002 Treatment: how does inflammatory phenotype influence response to treatment in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 Airway eosinophilia is not related to clinical and functional findings in a large group of severe refractory asthmatics Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006 An investigation of apoptotic eosinophil numbers in induced sputum: is there an association with asthma severity? Source: Eur Respir J 2001; 18: Suppl. 33, 247s Year: 2001 The use of induced sputum in clinical trials Source: Eur Respir J 2002; 20: 47S-50S Year: 2002 Expression of selected surface markers on macrophages in induced sputum from patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003 Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD Source: Eur Respir J, 55 (5) 1902119; 10.1183/13993003.02119-2019 Year: 2020 Study on levels of high sensitivity C reactive protein in asthmatic patients during exacerbation and remission and its correlation with pulmonary function Source: Annual Congress 2007 - Mechanisms of airway inflammation Year: 2007 Discrepancy of non-invasive inflammatory markers and lung function tests to current level of clinical control in childhood asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Heterogeneity of treatment response in bronchiectasis clinical trials Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 A study of T-regulatory cells as a possible marker of severity in bronchial asthma Source: Annual Congress 2010 - Cell biology and immunology of lung disease Year: 2010 Activated protein C inhibits neutrophil migration in allergic asthma: a randomised trial Source: Eur Respir J 2015; 46: 1636-1644 Year: 2015 IL-33 mRNA in induced sputum cells from allergic rhinitis and asthma patients: a marker of Th-2 phenotype status? Source: International Congress 2017 – Monitoring asthma control Year: 2017 Sputum cells profile and airway responsiveness in different asthma phenotypes in children Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood Year: 2010 How different operators performing sputum eosinophil differential cell counts may affect clinical decisions for severe asthma patients. Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 Relationship between asthma control test (ACT) and clinical, functional and inflammatory markers in treated and non treated asthmatics Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008